Replies to post #188068 on Biotech Values

[DewDiligence]

ACT’s PR on colossal ($21B/10-tranche) bond offering to pay for the AGN deal:

http://finance.yahoo.com/news/actavis-announces-pricing-public-offering-003000869.html

[DewDiligence]

AGN and ACT shareholders approve merger:

http://finance.yahoo.com/news/actavis-allergan-shareholders-approve-proposals-200500323.html

The closing of the transaction is expected to occur late in the first quarter or early in the second quarter of 2015, subject to the satisfaction or waiver of certain regulatory approvals and other customary closing conditions.